Tissue transglutaminase is increased in Huntington's disease brain

Journal of Neurochemistry

Volumn 73, Issue 5, 1999, Pages 2018-2027

  Lesort, Mathieu ^a   Chun, Wanjoo ^a   Johnson, Gail V W ^a   Ferrante, Robert J ^b,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Bedford VA Medical Center   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biochemistry; Huntington's disease; Immunohistochemistry; Polyglutamine; Striatum; Superior frontal cortex; Tissue transglutaminase

Indexed keywords

CALBINDIN; GLUTAMINE; HUNTINGTIN; MUTANT PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; NEOCORTEX; PRIORITY JOURNAL;

EID: 0032742674     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.02018.x     Document Type: Article

References (45)

1. Appelt D. M., Kopen G. C., Boyne L. J., and Balin B. J. (1996) Localization of transglutaminase in hippocampal neurons: implications for Alzheimer's disease. J. Histochem. Cytochem. 44, 1421-1427.
2. Beal M. F. (1996) Mitochondria, free radicals, and neurodegeneration. Curr. Opin. Neurobiol. 6, 661-666.
3. Beal M. F. (1998) Mitochondrial dysfunction in neurodegenerative diseases. Biochim. Biophys. Acta 1366, 211-223.
4. Cariello L., de Cristofaro T., Zanetti L., Cuomo T., Di Maio L., Campanella G., Rinaldi S., Zanetti P., Di Lauro R., and Varrone S. (1996) Transglutaminase activity is related to CAG repeat length in patients with Huntington's disease. Hum. Genet. 98, 633-635.
5. Chowdhury Z. A., Barsigian C., Chalupowicz G. D., Bach T. L., Garcia-Manero G., and Martinez J. (1997) Colocalization of tissue transglutaminase and stress fibers in human vascular smooth muscle cells and human umbilical vein endothelial cells. Exp. Cell Res. 23, 38-49.
6. Cooper A. J. L., Sheu K.-F. R., Burke J. R., Onodera O., Strittmatter W. J., Roses A. D., and Blass J. P. (1997a) Polyglutamine domains are substrates of tissue transglutaminase: does transglutaminase play a role in expanded CAG/poly-Q neurodegenerative diseases? J. Neurochem. 69, 431-434.
7. Cooper A. J. L., Sheu K. F., Burke J. R., Onodera O., Strittmatter W. J., Roses A. D., and Blass J. P. (1997b) Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length. Proc. Natl. Acad. Sci. USA 94, 12604-12609.
8. Davies S. W., Turmaine M., Cozens B. A., DiFiglia M., Sharp A. H., Ross C. A., Scherzinger E., Wanker E. E., Mangiarini L., and Bates G. P. (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 9, 537-548.
9. Davies S. W., Beardsall K., Turmaine M., DiFiglia M., Aronin N., and Bates G. P. (1998) Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions? Lancet 35, 131-133.
10. DiFiglia M., Sapp E., Chase K. O., Davies S. W., Bates G. P., Vonsattel J. P., and Aronin N. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993.
11. Ferrante R. J., Kowall N. W., Beal M. F., Richardson E. P. Jr., Bird E. D., and Martin J. B. (1985) Selective sparing of a class of striatal neurons in Huntington's disease. Science 230, 56l-563.
12. Ferrante R. J., Gutekunst C. A., Persichetti F., McNeil S. M., Kowall N. W., Gusella J. F., MacDonald M. E., Beal M. F., and Hersch S. M. (1997) Heterogeneous topographic and cellular distribution of huntingtin expression in the normal human neostriatum. J. Neurosci. 17, 3052-3063.
13. Folk J. E. (1983) Mechanism and basis for specificity of transglutaminase-catalyzed epsilon-(gamma-glutamyl) lysine bond formation. Adv. Enzymol. Relat. Areas Mol. Biol. 54, 1-56.
14. Fujita K., Ando M., Yamauchi M., Nagata Y., and Honda M. (1995) Alteration of transglutaminase activity in rat and human spinal cord after neuronal degeneration. Neurochem. Res. 20, 1195-1201.
15. Fujita K., Honda M., Hayashi R., Ogawa K., Ando M., Yamauchi M., and Nagata Y. (1998) Transglutaminase activity in serum and cerebrospinal fluid in sporadic amyotrophic lateral sclerosis: possible use as an indicator of extent of the motor loss. J. Neurol. Sci. 11, 53-57.
16. Gentile V., Sepe C., Calvani M., Melone M. A., Cotrufo R., Cooper A. J., Blass J. P., and Peluso G. (1998) Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains: a possible mechanism contributing to CAG-triplet diseases. Arch. Biochem. Biophys. 352, 314-321.
17. Gilad G. M., Varon L. E., and Gilad V. H. (1985) Calcium-dependent transglutaminase of rat sympathetic ganglion in development and after nerve injury. J. Neurochem. 44, 1385-1390.
18. Green H. (1993) Human genetic diseases due to codon reiteration: relationship to an evolutionary mechanism. Cell 74, 955-956.
19. Greenberg C. S., Birckbichler P. J., and Rice R. H. (1991) Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J. 5, 3071-3077.
20. Gutekunst C.-A., Li S.-H., Yi H., Mulroy J. S., Kuemmerle S., Jones R., Rye R., Ferrante R. J., Hersch S. M., and Li X.-J. (1999) Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J. Neurosci. 19, 2522-2534.
21. Hilton D. A., Love S., and Barber R. (1997) Increased endothelial expression of transglutaminase in glioblastomas. Neuropathol. Appl. Neurobiol. 23, 507-511.
22. Holmes F. E. and Haynes L. W. (1996) Superactivation of transglutaminase type 2 without change in enzyme level occurs during progressive neurodegeneration in the mnd mouse mutant. Neurosci. Lett. 213, 185-188.
23. Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
24. Jackson G. R., Salecker I., Dong X., Yao X., Arnheim N., Faber P. W., MacDonald M. E., and Zipursky S. L. (1998) Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron 21, 633-642.
25. Johnson G. V., Cox T. M., Lockhart J. P., Zinnerman M. D., Miller M. L., and Powers R. E. (1997) Transglutaminase activity is increased in Alzheimer's disease brain. Brain Res. 751, 323-329.
26. Kahlem P., Terre C., Green H., and Djian P. (1996) Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system. Proc. Natl. Acad. Sci. USA 93, 14580-14585.
27. Kahlem P., Green H., and Djian P. (1998) Transglutaminase action imitates Huntington's disease: selective polymerization of huntingtin containing expanded polyglutamine. Mol. Cell 1, 595-601.
28. Kim M., Lee H.-S., LaForet G., McIntyre C., Eileen J. M., Chang P., Kimn T. W., Williams M., Reddy P. H., Tagle D., Boyce F. M., Won L., Heller A., Aronin N., and DiFiglia M. (1999) Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition. J. Neurosci. 19, 964-973.
29. Klement I. A., Skinner P. J., Kaytor M. D., Yi H., Hersch S. M., Clark H. B., Zoghbi H. Y., and Orr H. T. (1998) Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95, 41-53.
30. Kojima S., Nara K., and Rifkin D. B. (1993) Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. J. Cell Biol. 121, 439-448.
31. Kosinski C. M., Cha J. H., Young A. B., Persichetti F., MacDonald M., Gusella J. F., Penney J. B. Jr., and Standaert D. G. (1997) Huntingtin immunoreactivity in the rat neostriatum: differential accumulation in projection and interneurons. Exp. Neurol. 144, 239-247.
32. Lesort M., Attanavanich K., Zhang J., and Johnson G. V. (1998) Distinct nuclear localization and activity of tissue transglutaminase. J. Biol. Chem. 273, 11991-11994.
33. Lorand L. (1998) DRPLA aggregation and transglutaminase, revisited. Nat. Genet. 20, 231.
34. Lorand L. and Conrad S. M. (1984) Transglutaminases. Mol. Cell. Biochem. 58, 9-35.
35. Lu S., Saydak M., Gentile V., Stein J. P., and Davies P. J. (1995) Isolation and characterization of the human tissue transglutaminase gene promoter. J. Biol. Chem. 270, 9748-9756.
36. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S. W., and Bates G. P. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493-506.
37. Melino G. and Piacentini M. (1998) Tissue transglutaminase in cell death: a downstream or a multifunctional upstream effector? FEBS Lett. 430, 59-63.
38. Ordway J. M., Tallaksen-Greene S., Gutekunst C. A., Bernstein E. M., Cearley J. A., Wiener H. W., Dure L. S. IV, Lindsey R., Hersch S. M., Jope R. S., Albin R. L., and Detloff P. J. (1997) Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell 9, 753-763.
39. Paulson H. L., Perez M. K., Trottier Y., Trojanowski J. Q., Subramony S. H., Das S. S., Vig P., Mandel J. L., Fischbeck K. H., and Pittman R. N. (1997) Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 19, 333-344.
40. Perutz M. F., Johnson T., Suzuki M., and Finch J. T. (1994) Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc. Natl. Acad. Sci. USA 91, 5355-5358.
41. Ross C. A. (1997) Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron 19, 1147-1150.
42. Saudou F., Finkbeiner S., Devys D., and Greenberg M. E. (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55-66.
43. Selkoe D. J., Abraham C., and Ihara Y. (1982) Brain transglutaminase: in vitro crosslinking of human neurofilament proteins into insoluble polymers. Proc. Natl. Acad. Sci. USA 79, 6070-6074.
44. Vonsattel J. P. and DiFiglia M. (1998) Huntington disease. J. Neuropathol. Exp. Neurol. 57, 369-384.
45. Vonsattel J. P., Myers R. H., Stevens T. J., Ferrante R. J., Bird E. D., and Richardson E. P. Jr. (1985) Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44, 559-577.